New drug combo targets tough cancers in early trial
Disease control
Recruiting now
This early-phase study tests a new experimental drug (LB-LR1109) in people with advanced solid tumors like lung, kidney, or skin cancer that no longer respond to standard treatments. The study has two parts: first, the drug is given alone to find the safest dose; second, it is co…
Phase: PHASE1 • Sponsor: LG Chem • Aim: Disease control
Last updated May 11, 2026 20:38 UTC